Accelerated approval drugs account for less than 1% of Medicaid spending, but states seek CMS approval to avoid coverage of these drugs and cut costs. States seek to limit coverage of drugs approved ...

Jul. 29—CHICAGO — On July 2, 2024, the State of Illinois received federal approval of its proposed Healthcare Transformation 1115 Demonstration waiver that will allow the Illinois Department of ...

Originally conceived to address one of our most daunting public health challenges—the AIDS epidemic—and reinforced for use in cancer and rare diseases, the Food and Drug Administration’s (FDA’s) ...

Congress should give states the power to not pay full price under Medicaid for drugs approved under the Food and Drug Administration’s accelerated approval pathway, a key advisory panel said. The ...

WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) today released, “Quantifying Impact of Accelerated Approval Drugs on Medicaid Spending: An Update through 2020 and ...

To improve their COVID-battered fiscal situations, some states are looking to cut Medicaid, which makes up nearly one-third of average state spending and whose enrollment increased by about 15 percent ...

Mar. 24—CHEYENNE — In an unprecedented vote, the Wyoming House of Representatives gave its final support Wednesday to a bill authorizing the expansion of Medicaid coverage to an estimated 24,000 ...

WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) today released, “Quantifying Impact of Accelerated Approval Drugs on Medicaid Spending: De Minimus Impact, Maximum ...

SALEM, Ore. (KTVZ) -- Oregon received federal approval Wednesday to pilot first-in-the-nation changes to the state’s Medicaid program over the next five years. Here's the rest of the Oregon Health ...

RICHMOND – The Virginia Department of Medical Assistance Services announced in a news release it has received federal approval for an emergency 1135 waiver giving the Medicaid agency the authority to ...

In a bid to lower prescription drug costs, a federal agency is recommending pharmaceutical companies pay higher Medicaid rebates if they have not completed required trials to confirm the effectiveness ...